Page 6 - Nasdaq Eigr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

StockNews.com initiated coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Rating) in a report released on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. Separately, Zacks Investment Research lowered Eiger BioPharmaceuticals from a “buy” rating to a “hold” rating in a research note on Wednesday, March 16th. Shares of NASDAQ:EIGR […]

Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Eiger BioPharmaceuticals, Inc. is a biopharmaceutical company which develops and manufactures drugs and therapies for the treatment of orphan diseases. Eiger BioPharmaceuticals, Inc., formerly […]